Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FINERENONE Cause Product prescribing issue? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Product prescribing issue have been filed in association with FINERENONE (Kerendia). This represents 1.5% of all adverse event reports for FINERENONE.

28
Reports of Product prescribing issue with FINERENONE
1.5%
of all FINERENONE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product prescribing issue From FINERENONE?

Of the 28 reports, 4 (14.3%) required hospitalization, and 1 (3.6%) were considered life-threatening.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FINERENONE. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does FINERENONE Cause?

Glomerular filtration rate decreased (250) Hyperkalaemia (209) Blood creatinine increased (181) Death (136) Blood potassium increased (132) Renal impairment (102) Dizziness (77) Acute kidney injury (71) Nausea (63) Urine albumin/creatinine ratio increased (60)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which FINERENONE Alternatives Have Lower Product prescribing issue Risk?

FINERENONE vs FINGOLIMOD FINERENONE vs FINGOLIMOD LAURYL FINERENONE vs FISH OIL FINERENONE vs FISH OIL\MEDIUM-CHAIN TRIGLYCERIDES\OLIVE OIL\SOYBEAN OIL FINERENONE vs FLAGYL

Related Pages

FINERENONE Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue FINERENONE Demographics